Seminoma secondary prevention

Revision as of 15:54, 6 May 2019 by Sogand (talk | contribs) (→‎Secondary Prevention)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Seminoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Seminoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

TNM
Stage Grouping

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Treatment - Stage I
Treatment - Stage II
Treatment - Stage III
Treatment - Recurrent

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Seminoma secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Seminoma secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Seminoma secondary prevention

CDC on Seminoma secondary prevention

Seminoma secondary prevention in the news

Blogs on Seminoma secondary prevention

Directions to Hospitals Treating Seminoma

Risk calculators and risk factors for Seminoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

Effective measures for the secondary prevention of seminoma include regular follow-ups for every 2–6 months for the first 3 years and every 6–12 months after 3 years. Tests are often part of follow-up care include blood tests to check serum tumor marker levels, chest x-rays, and CT scans of the abdomen and pelvis.

Secondary Prevention

References

  1. Boujelbene N, Cosinschi A, Boujelbene N, Khanfir K, Bhagwati S, Herrmann E, Mirimanoff RO, Ozsahin M, Zouhair A (August 2011). "Pure seminoma: a review and update". Radiat Oncol. 6: 90. doi:10.1186/1748-717X-6-90. PMC 3163197. PMID 21819630.
  2. Paly, Jonathan J.; Efstathiou, Jason A.; Hedgire, Sandeep S.; Chung, Peter W.M.; O’Malley, Martin; Shah, Anand; Bekelman, Justin E.; Harisinghani, Mukesh; Shipley, William U.; Zietman, Anthony L.; Beard, Clair (2013). "Mapping patterns of nodal metastases in seminoma: Rethinking radiotherapy fields". Radiotherapy and Oncology. 106 (1): 64–68. doi:10.1016/j.radonc.2012.12.002. ISSN 0167-8140.

Template:WH Template:WS